Baxter International is a global healthcare company that develops, manufactures, and markets products for hospitals, healthcare providers, and patients worldwide, focusing on renal care, medication delivery, and critical care.
A noteworthy fixed-income instrument currently attracting attention in the market is the bond (ISIN: US071813BV00; CUSIP: 071813BV0) issued by Baxter International, a prominent global healthcare company based in the United States, specializing in essential medical products and therapies; this particular USD-denominated debt security, issued in the United States, carries an annual interest rate of 3.75% and a maturity date of September 30, 2025, features semi-annual interest payments and represents a total issuance size of $750,000,000, with a minimum acquisition size set at $2,000, and is presently valued on the market at 112.958% of its par.
|